Clinical trial
URACYST® For the Treatment of GAG Deficient Interstitial Cystitis
NCT00150488 · Dr. J. Curtis Nickel, Other · Completed
Key facts
| NCT number | NCT00150488 |
|---|---|
| Title | URACYST® For the Treatment of GAG Deficient Interstitial Cystitis |
| Official title | URACYST® For the Treatment of GAG Deficient Interstitial Cystitis |
| Lead sponsor | Dr. J. Curtis Nickel, Other |
| Collaborators | Stellar Pharmaceuticals Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Painful Bladder Syndrome, Interstitial Cystitis |
| Intervention type | Device |
| Interventions | Uracyst |
| Enrollment | 53 |
| Start date | Sep 1, 2005 |
| Primary completion | Jan 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Sep 8, 2005 |
| Last update posted | Jul 27, 2023 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: